Clinical trials
Phase 4 Inflammation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Terminated | 8 |
| Recruiting | 7 |
| Unknown status | 4 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 4 |
| University of North Carolina, Chapel Hill | 4 |
| Massachusetts General Hospital | 3 |
| Oregon Health and Science University | 3 |
| University at Buffalo | 3 |
| University of California, San Francisco | 3 |
| University of Pennsylvania | 3 |
| Mayo Clinic | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Purdue University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 73 |
| Diabetes Mellitus, Type 2 | 8 |
| Insulin Resistance | 8 |
| Coronary Artery Disease | 6 |
| Atherosclerosis | 5 |
| Obesity | 5 |
| Diabetes Mellitus | 4 |
| Pain | 4 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.